US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Freenome, Inc.

13.81

+0.30002.22%

Pre-market: 13.900.0900+0.65%08:06 EDT

Volume:735.07K

Turnover:10.15M

Market Cap:1.48B

PE:-200.14

High:14.13

Open:13.33

Low:13.33

Close:13.51

52wk High:14.47

52wk Low:9.95

Shares:107.00M

Float Shares:76.43M

Volume Ratio:0.62

T/O Rate:0.96%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0690

EPS(LYR):-8.2800

ROE:--

ROA:--

PB:-1.06

PE(LYR):-1.67

Loading ...

Overview Company News Filings

Freenome Initiated at Buy by Guggenheim

Freenome, Inc. : Guggenheim Initiates Coverage with Buy Rating; Price Target $21

THOMSON REUTERS

Freenome initiated with a Buy at Guggenheim

U.S. Research Roundup-Amgen, Analog Devices, Moderna

Freenome Registers Up To 75.2 Million Shares For Sale

MT Newswires Live

Freenome - Selling Securityholders May Offer up to 75,188,742 Shares of Common Stock - SEC Filing

THOMSON REUTERS

Freenome Shares Rise After Jefferies Initiates Coverage

MT Newswires Live

Correction: Jefferies Initiates Freenome at Buy, With $17 Price Target

MT Newswires Live

Freenome, Inc. : Btig Initiates Coverage with Buy Rating; Price Target $17

THOMSON REUTERS

BTIG Initiates Freenome at Buy, With $17 Price Target

MT Newswires Live

Jefferies Initiates Freenome at Hold, With $17 Price Target

MT Newswires Live

Freenome Price Target Announced at $17.00/Share by BTIG

Freenome initiated with a Buy at Jefferies

Freenome Initiated at Outperform by Leerink Partners

Leerink Partners Capital Initiates Freenome With Outperform Rating, With $18 Price Target

MT Newswires Live

Freenome Says It Has Obtained FDA Breakthrough Device Designation for Lung Cancer Screening Test

MT Newswires Live

FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based Simplescreen™ Lung Cancer Screening Test

THOMSON REUTERS

Freenome, Abbott Laboratories' Colorectal Cancer Screening Test Approved by FDA; Freenome Earns $100 Million Milestone Payment

MT Newswires Live

Freenome, Abbott announce FDA approval of SimpleScreen CRC

FDA Approves Freenome’s Simplescreen™ Crc Blood-Based Screening Test; Abbott to Commercialize in the U.S.

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/FRNM/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FRNM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FRNM\",,,,,undefined,":{"symbol":"FRNM","market":"US","secType":"STK","nameCN":"Freenome, Inc.","latestPrice":13.81,"timestamp":1787342400000,"preClose":13.51,"halted":0,"volume":735071,"hourTrading":{"tag":"盘前","latestPrice":13.9,"preClose":13.81,"latestTime":"08:06 EDT","volume":116,"amount":1602.2999960000002,"timestamp":1787573191471,"change":0.09,"changeRate":0.006517,"amplitude":0.007241},"delay":0,"changeRate":0.022205773501110342,"floatShares":76431399,"shares":107000000,"eps":-0.069,"marketStatus":"Pre-Mkt","change":0.3,"latestTime":"08-24 08:09:46 EDT","open":13.33,"high":14.13,"low":13.33,"amount":10148577.669105,"amplitude":0.059215,"askPrice":13.95,"askSize":87,"bidPrice":11.85,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.069,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"listingDate":1718164800000,"exchange":"NASDAQ","adjPreClose":13.81,"preHourTrading":{"tag":"盘前","latestPrice":13.9,"preClose":13.81,"latestTime":"08:06 EDT","volume":116,"amount":1602.2999960000002,"timestamp":1787573191471,"change":0.09,"changeRate":0.006517,"amplitude":0.007241},"postHourTrading":{"tag":"盘后","latestPrice":13.81,"preClose":13.81,"latestTime":"19:30 EDT","volume":144,"amount":1996.76,"timestamp":1787355007346,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.6158317994619813},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FRNM\",,,,,undefined,":{"symbol":"FRNM","floatShares":76431399,"roa":"--","roe":"--","lyrEps":-8.279999,"volumeRatio":0.6158317994619813,"shares":107000000,"dividePrice":0,"high":14.13,"amplitude":0.059215,"preClose":13.51,"low":13.33,"week52Low":9.95,"pbRate":"-1.06","psRate":"41.73","week52High":14.47,"institutionHeld":0,"latestPrice":13.81,"committee":0.069519,"eps":-0.069,"divideRate":0,"volume":735071,"delay":0,"ttmEps":-0.069,"open":13.33,"prevYearClose":13.03,"prevWeekClose":13.81,"prevMonthClose":11.15,"prevQuarterClose":10.88,"fiveDayClose":11.56,"twentyDayClose":11.24,"sixtyDayClose":11.21},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FRNM\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-15","symbol":"FRNM","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1784088000000,"reportTimeType":"pre","actualEps":-0.01}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FRNM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FRNM\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FRNM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FRNM","date":"2026-08-21","current":-200.144928,"percent":0.055556,"low":-6.835818,"twenty":-6.21894,"median":-5.707382,"eighty":-5.471664,"high":-5.010259,"avg":-5.811647,"sd":0.529714,"marketCap":1524707608},"quantilePoints":[{"date":"2026-07-31","current":-5.010259,"twenty":-5.523823,"median":-5.223408,"eighty":-5.031323,"marketCap":1127448482},{"date":"2026-08-07","current":-5.471664,"twenty":-5.549902,"median":-5.471664,"eighty":-5.259016,"marketCap":1231277572},{"date":"2026-08-14","current":-5.822733,"twenty":-5.804678,"median":-5.556923,"eighty":-5.443578,"marketCap":1310277966},{"date":"2026-08-21","current":-6.775635,"twenty":-6.21894,"median":-5.707382,"eighty":-5.471664,"marketCap":1524707608}],"updateTime":1787570495379},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FRNM\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660287657","title":"Freenome Initiated at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2660287657","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660287657?lang=en_us&edition=fundamental","pubTime":"2026-08-20 21:21","pubTimestamp":1787232060,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FRNM/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FRNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660283279","title":"Freenome, Inc. : Guggenheim Initiates Coverage with Buy Rating; Price Target $21","url":"https://stock-news.laohu8.com/highlight/detail?id=2660283279","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660283279?lang=en_us&edition=fundamental","pubTime":"2026-08-20 18:24","pubTimestamp":1787221440,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nFWN44H0B0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRNM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660283797","title":"Freenome initiated with a Buy at Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2660283797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660283797?lang=en_us&edition=fundamental","pubTime":"2026-08-20 18:20","pubTimestamp":1787221221,"startTime":"0","endTime":"0","summary":"Guggenheim analyst Subbu Nambi initiated coverage of Freenome (FRNM) with a Buy rating and $21 price target Published first on TheFly – the ultimat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/freenome-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/freenome-initiated-with-a-buy-at-guggenheim-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRNM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660811404","title":"U.S. Research Roundup-Amgen, Analog Devices, Moderna","url":"https://stock-news.laohu8.com/highlight/detail?id=2660811404","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660811404?lang=en_us&edition=fundamental","pubTime":"2026-08-20 15:47","pubTimestamp":1787212055,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Amgen, Analog Devices, ModernaAug 20 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Amgen, Analog D","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260820:nL4N44H0HP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LWAY","TRUH","RLAY","EPR","IBBQ","KIDS","ABBV","BILL","MRK","XNTK","ADSK","UNCY","PJP","SNOW","ARTY","FRNM","TJX","LOW","IHF","SPHR","WHD","AMGN","SMHX","NRGV","MRNA","HCA","WOLF","MSGE","LNSR","WISE","ALL","APA","ALIT","NIQ","PCTY","WDAY","PGR","CING","AIPI","XLV","IHE","KBWP","EL","ADI","CRWD","MRVL","GKOS","RARE","TGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660497569","title":"Freenome Registers Up To 75.2 Million Shares For Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2660497569","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660497569?lang=en_us&edition=fundamental","pubTime":"2026-08-19 05:19","pubTimestamp":1787087953,"startTime":"0","endTime":"0","summary":"Freenome (FRNM) on Tuesday filed a registration statement covering the potential resale of up to 75.2 million shares of common stock by selling securityholders.Freenome said it will not receive procee","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FRNM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492225","title":"Freenome - Selling Securityholders May Offer up to 75,188,742 Shares of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492225","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492225?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:53","pubTimestamp":1787086438,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F13X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","FRNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660434569","title":"Freenome Shares Rise After Jefferies Initiates Coverage","url":"https://stock-news.laohu8.com/highlight/detail?id=2660434569","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660434569?lang=en_us&edition=fundamental","pubTime":"2026-08-18 02:51","pubTimestamp":1786992706,"startTime":"0","endTime":"0","summary":"Freenome  shares were up more than 11% in Monday trading after Jefferies initiated coverage of the stock with a buy rating and a price target of $17.Trading volume stood at more than 1.1 million shares, compared with a daily average of about 372,000.Price: 12.85, Change: +1.29, Percent Change: +11.16","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FRNM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660828894","title":"Correction: Jefferies Initiates Freenome at Buy, With $17 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2660828894","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660828894?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:28","pubTimestamp":1786966080,"startTime":"0","endTime":"0","summary":"(Corrects rating in headline.)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FRNM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660816804","title":"Freenome, Inc. : Btig Initiates Coverage with Buy Rating; Price Target $17","url":"https://stock-news.laohu8.com/highlight/detail?id=2660816804","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660816804?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:30","pubTimestamp":1786962657,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nFWN44E07D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRNM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660489795","title":"BTIG Initiates Freenome at Buy, With $17 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2660489795","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660489795?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:12","pubTimestamp":1786961543,"startTime":"0","endTime":"0","summary":"(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","FRNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660897184","title":"Jefferies Initiates Freenome at Hold, With $17 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2660897184","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660897184?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:11","pubTimestamp":1786961518,"startTime":"0","endTime":"0","summary":"Jefferies Initiates Freenome at Hold, With $17 Price Target","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FRNM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660489768","title":"Freenome Price Target Announced at $17.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2660489768","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660489768?lang=en_us&edition=fundamental","pubTime":"2026-08-17 18:11","pubTimestamp":1786961460,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FRNM/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FRNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660830094","title":"Freenome initiated with a Buy at Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2660830094","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660830094?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:40","pubTimestamp":1786956051,"startTime":"0","endTime":"0","summary":"Jefferies initiated coverage of Freenome (FRNM) with a Buy rating and $17 price target The company is developing a portfolio of blood-based cancer ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/freenome-initiated-with-a-buy-at-jefferies-thefly-news-4?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/freenome-initiated-with-a-buy-at-jefferies-thefly-news-4?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FRNM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659235011","title":"Freenome Initiated at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2659235011","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659235011?lang=en_us&edition=fundamental","pubTime":"2026-08-15 00:37","pubTimestamp":1786725420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FRNM/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FRNM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659485148","title":"Leerink Partners Capital Initiates Freenome With Outperform Rating, With $18 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2659485148","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659485148?lang=en_us&edition=fundamental","pubTime":"2026-08-14 18:26","pubTimestamp":1786703180,"startTime":"0","endTime":"0","summary":"Leerink Partners Capital Initiates Freenome With Outperform Rating, With $18 Price Target","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FRNM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658086839","title":"Freenome Says It Has Obtained FDA Breakthrough Device Designation for Lung Cancer Screening Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2658086839","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658086839?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:29","pubTimestamp":1786541387,"startTime":"0","endTime":"0","summary":"Freenome  has obtained breakthrough device designation for its investigational lung cancer screening test SimpleScreen Lung from the US Food and Drug Administration, the company said Wednesday.The designation applies to the proposed use of SimpleScreen Lung in adults aged 50 to 80 years who have at least a 20 pack-year smoking history and are currently participating in guideline-recommended lung cancer screening, according to a statement.Freenome said that the clinical evaluation of the test is ongoing.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","FRNM","LABU","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658970664","title":"FDA Grants Breakthrough Device Designation to Freenome’s Blood-Based Simplescreen™ Lung Cancer Screening Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2658970664","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658970664?lang=en_us&edition=fundamental","pubTime":"2026-08-12 21:00","pubTimestamp":1786539601,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nTUA5YNCW2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","FRNM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654504880","title":"Freenome, Abbott Laboratories' Colorectal Cancer Screening Test Approved by FDA; Freenome Earns $100 Million Milestone Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2654504880","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654504880?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:50","pubTimestamp":1785156615,"startTime":"0","endTime":"0","summary":"Freenome  and Abbott Laboratories  said Monday that the US Food and Drug Administration approved SimpleScreen CRC, a blood-based colorectal cancer screening test.The companies said the new blood-based screening option is intended for adults 45 and older who are at average risk for the disease.Under the terms of a commercial agreement between Freenome and Abbott, Freenome will receive a $100 million milestone payment from Abbott for the FDA approval, while Abbott will exclusively commercialize the test in the US this fall.Shares of Freenome were up close to 10% pre-bell.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2211815571.USD","BK4533","LU1023059063.AUD","SG9999002232.USD","ABT.AU","LABU","BK4581","IE00BJJMRZ35.SGD","LU1914381329.SGD","LU1989763690.USD","LU1691799644.USD","IHI","BK4585","SGXZ23171101.USD","BK4588","LU2237957902.USD","IE00BJT1NW94.SGD","LU2237957811.SGD","IE0002141913.USD","LU2112291526.USD","LU0882574055.USD","LU1057294990.SGD","SGXZ41872573.SGD","BK4566","LU0266013472.USD","LU0289739699.SGD","LU2324357040.USD","LU2089984988.USD","IE0009355771.USD","LU0868494617.USD","SG9999004303.SGD","BK4568","LU1721429741.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","FRNM","IE00B4R5TH58.HKD","LU0234572021.USD","LU1989763427.SGD","LU0122379950.USD","LU0432979614.USD","LU1721429402.USD","BK4592","TMED","ABT","LU1061106388.HKD","LU0114720955.EUR","PJP","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654010379","title":"Freenome, Abbott announce FDA approval of SimpleScreen CRC","url":"https://stock-news.laohu8.com/highlight/detail?id=2654010379","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654010379?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:16","pubTimestamp":1785154580,"startTime":"0","endTime":"0","summary":"Freenome (FRNM) and Abbott (ABT) announced that the FDA has approved SimpleScreen CRC, a new blood-based screening option for colorectal cancer in ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/freenome-abbott-announce-fda-approval-of-simplescreen-crc-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/freenome-abbott-announce-fda-approval-of-simplescreen-crc-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1914381329.SGD","TECB","LU1691799644.USD","SG9999002224.SGD","CRC","RSPH","GDOC","LABU","IE0002141913.USD","LU0266013472.USD","LU0170899867.USD","NVIB","LU1721429741.USD","LU2468319806.SGD","MEDI","BK4504","IEIH","TBXU","PJP","LU1061106388.HKD","BK4213","SG9999002232.USD","BBP","FRNM","XLVX","IDNA","IYH","LU2133065610.SGD","GNMX","IHI","IBB","PINK","SGXZ41872573.SGD","PSCH","BK4082","LU0266512127.USD","ABT","TMED","LFSC","LU2112291526.USD","LU0868494617.USD","LU1721429402.USD","SYNB","MRNY","BK4585","MRNX","BK4588","FRTY","BMED","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654316017","title":"FDA Approves Freenome’s Simplescreen™ Crc Blood-Based Screening Test; Abbott to Commercialize in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2654316017","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654316017?lang=en_us&edition=fundamental","pubTime":"2026-07-27 20:00","pubTimestamp":1785153604,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nTUA2K51KP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FRNM"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":26,"code":"91000000","status":"200"}]}}